O ver the last 20 years, the standard treatment of acute cholecystitis has evolved from open to laparoscopic cholecystectomy. In the setting of severe acute cholecystitis or in high-risk patients, open cholecystostomy tubes serve as a less invasive procedure. 1 Frequently, the choice of an open cholecystostomy tube is made in the operating room, but occasionally the decision is made preoperatively. 2 Percutaneous cholecystostomy tubes (PCTs) were introduced approximately 30 years ago as a minimally invasive method for biliary drainage. 3 As the transition from open to laparoscopic cholecystectomy has occurred, PCT placement has been established as a treatment option for acute cholecystitis in elderly and critically ill patients. [4] [5] [6] [7] [8] [9] [10] Since its inception, no studies have evaluated the changing trends and outcomes of PCT. In addition, no study has directly compared patients who underwent percutaneous versus operative intervention. The objective of this study was to compare PCTs to operative management of acute cholecystitis and examine changing trends in the utilization of PCTs over 2 time periods in an integrated health system.
METHODS
Gundersen Health System is a 325-bed community-based teaching hospital with a general surgery residency and minimally invasive surgery fellowship. Following institutional review board approval, a retrospective review of the medical records of consecutive patients who were admitted for acute cholecystitis from April 1998 through December 2009 (time period 2) was performed. The diagnosis of acute cholecystitis was based on clinical, laboratory, and image findings. The institution's comprehensive electronic medical record system was queried by procedure and diagnosis codes to identify patients who underwent PCT placement for acute cholecystitis. Patients who underwent operative management of acute cholecystitis immediately before and after each patient who underwent PCT placement served as controls, and were matched 2:1 with PCT cases. The contemporary series was then compared with previously published institutional data from a cohort of PCT patients from March 1989 to March 1998 (time period 1) to compare trends in utilization. 11 Variables analyzed included demographical data, procedural data, and outcomes. Charlson comorbidity index was calculated for all patients in time period 2.
12 Comorbid conditions were defined as follows: cardiovascular disease: coronary artery disease, New York Heart Association functional classification system III or IV, moderate to severe valve disease, peripheral vascular disease, cerebral vascular disease; pulmonary disease: chronic obstructive pulmonary disease, pulmonary fibrosis, chronic bronchitis; malignancy: not including nonmelanoma skin cancer, with or without metastases; chronic renal insufficiency: glomerular filtration rate less than 60 mL/min/1.73m 2 , baseline creatinine more than 1.5 mg/dL; liver disease: moderate to severe liver disease; organ failure: as defined by the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. 13 Placement of PCTs was accomplished under local anesthesia using ultrasound or computed tomographic guidance at the discretion of the interventional radiologist. Fluoroscopy was used to confirm guidewire placement and Seldinger technique was used to place 8 to 10 French pigtail catheters. A subcostal approach was preferred over a transhepatic approach. Patients requiring long-term drainage were treated with routine catheter exchanges every 3 months. Decision for drain removal or interval cholecystectomy was based on clinical status and surgeon judgment.
Statistical analysis included the Student t test, χ 2 , Fisher exact test, Wilcoxon rank sum test, and Kaplan-Meier analysis where appropriate. A P < 0.05 was considered significant.
RESULTS
A total of 1775 patients were admitted to the hospital for acute cholecystitis during time period 2. Acute cholecystitis was managed medically in 73 patients (4%); with PCTs in 143 patients (8%), and operatively in 1559 patients (88%).
time-matched controls that underwent cholecystectomy. As expected, differences were observed when comparing the PCT and cholecystectomy groups with regard to demographical data, length of stay, need for an intensive care unit stay, and comorbidities (Table 1) . Pathology and imaging results revealed calculous cholecystitis in 366 patients (85%) and acalculous cholecystitis in 56 patients (13%), overall. The remaining 7 patients (2%) were found to have sludge. Twenty-six patients (9%) in the cholecystectomy group were diagnosed with acalculous cholecystitis, whereas 30 of the PCT patients (21%) had acalculous cholecystitis on pathology or imaging assessments (P = 0.001). Thirty-day mortalities in the PCT and cholecystectomy groups were 12% and 0.4%, respectively (P = 0.001). Median follow-up for survivors was 30.5 and 41.8 months in the PCT and cholecystectomy groups, respectively. On the basis of Kaplan-Meier analysis, long-term survival was higher in the cholecystectomy group (Fig.) .
PCT Outcomes
PCT placement was technically successful in 143 of 144 patients (99%). Only patients with successful PCT placement were included in the analysis. After PCT placement, 60 patients (42%) showed clinical improvement within 24 hours, and 130 (91%) improved overall. Among the 13 patients who did not improve with PCT placement, 2 required urgent cholecystectomy (1 laparoscopic and 1 open) for failure of PCT management and 11 died during the index hospitalization. The median duration of PCT drainage was 48.5 days. During this time, 21 patients (14.7%) developed PCT-related complications, none of which required operative intervention. Complications included dislodgement in 10 (7%), bile leak in 7 (5%), pain in 4 (3%), occlusion in 4 (3%), and infection in 2 patients (1%). Median time to catheter dislodgement was 45.5 days, and treatment included replacement or observation without adverse outcomes. All bile leaks were extra-abdominal and treated with upsizing of the catheter as clinically indicated. Occlusion was treated by catheter replacement. Thirteen patients (9%) required tube exchanges or replacements because of the aforementioned complications. Fifty-nine patients (41%) who underwent PCT placement subsequently underwent interval cholecystectomy, and 78% of these cholecystectomies were performed laparoscopically, 14% were converted to open procedures, and the remaining 8% were performed as a planned open
FIGURE.
Kaplan-Meier analysis of survival after PCT and cholecystectomy performed from 1998 through 2009 (P = 0.001).
cholecystectomy. Overall, 13 PCT patients (9%) died during their initial hospitalization and another 4 died within 30 days. Six of these deaths were attributed to biliary pathology. The majority of the remaining deaths were attributed to multisystem organ failure due to the patients' underlying comorbid conditions, and not secondary to biliary pathology.
Trends in PCT Use Over Time
Use of PCT increased from 22 patients (0.8%) in time period 1 to 143 patients (8%) in time period 2. No patient undergoing PCT in time period 1 was categorized as American Society of Anesthesiologist's class I or II, whereas in time period 2, 18% were categorized as American Society of Anesthesiologist's class I or II (Table 2) . Thirtyday mortality among patients undergoing PCTs decreased over time, from 36% in the first time period to 12% in the second time period. The 30-day mortality rate for patients with an American Society of Anesthesiologist's class III or IV in the second time period was 13%.
DISCUSSION
Advances in minimally invasive surgery have prompted a shift in the treatment of acute cholecystitis from open cholecystectomy to laparoscopic cholecystectomy. The PCT has also emerged as a treatment option for elderly and critically ill patients. This study demonstrates the increased use of PCT for the treatment of acute cholecystitis over a 20-year period at a single institution.
The PCT was utilized in older patients with increased comorbidities compared with matched operative controls; however, PCT was used in less morbid patients in the more recent decade. This has resulted in a reduction in 30-day mortality over time (36% and 12% in time periods 1 and 2, respectively) in patients managed with a PCT. Even when analyzing only patients with American Society of Anesthesiologist's class III or IV in the second time period, there was a significant reduction in mortality from 36% to 13%. The improved mortality rate can be partially explained by dramatic differences in American Society of Anesthesiologist's classification between the 2 time periods. In the first time period, 100% of patients were American Society of Anesthesiologist's class III or IV compared with only 80% in the second time period. The improved mortality in recent years is consistent with rates reported in current literature. Mortality rates before 1995 have been reported to be 22.1% and have decreased to 13.3% since that time.
14 It is difficult to deduce whether the improved mortality rate is a result of the intervention or patient selection. The decreased American Society of Anesthesiologist's class and Charlson comorbidity index demonstrated in the current study suggest that patient selection may play a major role in the reduced mortality rates observed.
Although no prospective randomized studies directly comparing PCT to cholecystectomy exist, 2 studies comparing PCTs with other treatment modalities have been published. One study compared gallbladder aspiration with PCT and ultimately supported the use of PCT. 15 A second study found no difference in mortality rates when comparing high-risk surgical patients treated with PCT versus antibiotics and supportive cares. 16 Another study compared PCT and early laparoscopic cholecystectomy with medical management and delayed laparoscopic cholecystectomy. 8 This study concluded that PCT allowed for resolution of sepsis in high-risk patients so that early laparoscopic cholecystectomy could be performed. Objective analysis of this article revealed that 16% of PCT patients were unable to undergo an early laparoscopic cholecystectomy, there was an 8% complication rate associated with PCT, and 5% required conversion to open cholecystectomy. When this data was examined critically, 29% were unable to be treated by early laparoscopic cholecystectomy or experienced complications due to PCT. Despite the lack of a definitive prospective trial to address this topic, increasing PCT use at our institution echoes national and international trends and is supported by current guidelines. 17, 18 Current guidelines for appropriate utilization of PCT in acute cholecystitis exist but are based on limited level II evidence. 17, 18 The Society for American Gastrointestinal and Endoscopic Surgeons guidelines state that in critically ill patients with acute cholecystitis radiographically guided PCT is an effective temporizing measure. 18 The Tokyo guidelines recommend consideration of PCT in moderate acute cholecystitis if the gallbladder is markedly inflamed. 17 Moderate acute cholecystitis is defined as one or more of the following characteristics: leukocytosis more than 18,000; painful, palpable right upper quadrant mass, symptoms for longer than 72 hours, and marked local inflammation as defined by 8-mm wall thickness. 19 In severe acute cholecystitis, the Tokyo guidelines recommend urgent drainage or cholecystectomy. 17 Severe acute cholecystitis is defined as one or more of the following characteristics: cardiovascular, neurological, respiratory, renal, hepatic, or hematological dysfunction attributed to the underlying process of acute cholecystitis. 19 Both of these guidelines can be interpreted broadly.
No compelling prospective data directly comparing PCT and cholecystectomy exist. A systematic review of PCT for treatment of acute cholecystitis was published in 2009.
14 Unlike the published guidelines, the review states that no definitive recommendations regarding treatment with PCT can be made. Historically, overall mortality rates among patients with acute cholecystitis treated with PCT have been reported as high as 59%, 20 whereas more recent literature highlights improving mortality rates of 13.3%.
14 Mortality associated with PCT treatment is significantly higher when compared with operative treatment of acute cholecystitis. The highest reported mortality rate after cholecystectomy in elderly patients with comorbidities is 19%, with an average mortality rate of 4.5%. 14, 21 The improved mortality for operatively treated acute cholecystitis is likely influenced by surgeon recommendation for PCT for patients with a more severe comorbidity status rather than treatment selection; similar results were found in this study. Despite the potential implications of selection bias, PCT mortality rates approximately 3 times higher than that of operatively managed patients are striking. The overall trend of decreasing mortality associated with PCT is promising, but the mortality is still significantly higher than in operatively managed patients. Although this can be partially explained by patient selection, care must be taken to not overutilize this modality.
Multiple case series have demonstrated that PCT can temporize a patient with multiple comorbid conditions with acute cholecystitis. This has been established in the literature and in the clinical arena. This has occurred at the cost of higher mortality, complications associated with PCT, and a delay in definitive therapy.
This study compares favorably to the current literature when comparing rates of clinical success (91% vs 85.2%), procedurerelated mortality (0% vs 0.36%), overall 30-day mortality (12% vs 15.4%), PCT-related complications (14.7% vs 14.8%) and interval cholecystectomy (42% vs 38.1%), respectively. 14 Limitations of this study include the inherent limitations of a retrospective analysis and that the data were limited to a single institution. Obvious selection bias for elderly comorbid patients being placed in the PCT group exists. In addition, PCT use was greater during the second decade of the study, which represents a major change in practice. Potential reasons for this change in utilization are multifactorial and include increased compliance with current treatment guidelines for acute cholecystitis, and improvements in interventional radiology access and techniques. An additional possible cause of the change is increased transparency of surgical outcomes. Mandatory reporting, pay for performance, HealthGrades, and the National Surgical Quality Improvement Program are becoming integral components of modern surgical care, which did not exist in the previous decade. This may lead to risk aversion and selection of PCTs instead of operative management.
CONCLUSIONS
This is the largest series comparing comorbidities of cholecystectomy and PCT patients. In addition, this study reports the changing trends of PCT observed over 2 decades. This study demonstrates that patients undergoing PCT had increased illness severity when compared with the operatively managed cohort. PCT use increased substantially over the past 2 decades. Over time, PCT use increased in less morbid patients with decreasing mortality rates. Despite the success of PCT placement and decreasing mortality rates with this technique, this modality carries its own set of complications, delays definitive therapy, and has a higher associated mortality than definitive surgical therapy. Although PCT undoubtedly has a role in the management of acute cholecystitis, further study is required to identify which subset of patients will experience the greatest benefit from this technique.
